NCT01853475View on ClinicalTrials.gov

Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Malaria

Interventions

DRUG

PQP tablets 960mg

Piperaquine phosphate tablets 960mg

DRUG

PQP tablets 1440mg

Piperaquine phosphate tablets 1440mg

DRUG

OZ439+TPGS 800mg

OZ439+TPGS prototype formulation 800mg

DRUG

OZ439 PIB 800mg

OZ439 Powder in Bottle Aqueous Solution 800mg

Trial Locations (1)

CR7 7YE

Richmond Pharmacology Limited, Croyden

All Listed Sponsors

collaborator

Richmond Pharmacology Limited

INDUSTRY

lead

Medicines for Malaria Venture

OTHER

NCT01853475 - Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State | Biotech Hunter | Biotech Hunter